The Game-Changing Potential of Targeting RNA with Small Molecules: More Than Turning the Undruggable...
By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx)
Once considered impossible, targeting RNA with small molecules has the potential to be a game-changer. It’s convincing enough to industry veteran Michael...
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
Shanghai, China & San Diego, California May 6, 2019 - WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired...
SPOTLIGHT
STAY CONNECTED
WUXI NEWS
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
SHANGHAI, 24 July,
2019:
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec –
announces that its Analytical Service Unit (ASU) in...
